April 8, 2025

Prestige Scientific Announces Successfully Completed Search for a Senior Director of Global Regulatory Affairs

Completed Searches

Milford, MA – Prestige Scientific is excited to announce the successfully completed search for a Senior Director of Global Regulatory Affairs with our partner, a leading international biopharmaceutical company.

The candidate hired for this role has over two decades of regulatory affairs experience, with a strong emphasis on clinical strategy since 2016. They have served in both leadership roles and as a hands-on contributor, acting as the primary liaison with regulatory agencies including the FDA and international counterparts across Europe and Asia. This individual’s expertise spans multiple therapeutic areas such as oncology, psychiatry, metabolism and endocrinology, and ophthalmology. They have successfully led cross-functional teams and global programs, notably advancing efforts in oncology, including work on clinical holds and strategic agency interactions. They also bring practical experience in lifecycle management and regulatory submissions, making them a well-rounded and impactful regulatory leader.

Prestige presented 6 highly qualified individuals for this role, the hired candidate was presented 4 days from the start of the search, and the search was completed in 23 days. Congratulations to our search team for this successful project! Congratulations to our Clinical search team for this successful project! Congratulations to our Regulatory search team for this successful project!

About Prestige Scientific:

Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.